Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison - Scorecard - MDSpire
Advertisement
Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison
Clinical Scorecard: Comparison of Glandular Tissue and Anatomical Landmark Methods for CTV Delineation in Postoperative Radiotherapy for Breast Cancer: A Dosimetric Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Comparison of CTV delineation methods focusing on dosimetric differences: anatomical landmark-based vs. glandular tissue-based.
Target Population
Care Setting
Key Highlights
Further studies needed to assess clinical implications of dosimetric differences.
Guideline-Based Recommendations
Diagnosis
Follow ESTRO guidelines for diagnosis of breast cancer.
Management
Consider individualized treatment plans based on CTV delineation.
Monitoring & Follow-up
Regular follow-up for assessing treatment-related toxicities.
Risks
Monitor for potential radiation-induced cardiac and pulmonary injuries.
Patient & Prescribing Data
48 patients aged 32–67 years (mean 49.35 ± 8.57).
Patients underwent IMRT with prescribed dose of 50 Gy in 25 fractions.
Clinical Best Practices
Follow specific ESTRO guidelines for CTV delineation methods.
